Aperio Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.36M | Buy |
5,328
+208
| +4% | +$53K | ﹤0.01% | 1429 |
|
|
2020
Q3 | $1.27M | Buy |
5,120
+251
| +5% | +$62.5K | ﹤0.01% | 1327 |
|
|
2020
Q2 | $1.69M | Buy |
4,869
+909
| +23% | +$316K | 0.01% | 1181 |
|
|
2020
Q1 | $1.06M | Buy |
3,960
+955
| +32% | +$256K | ﹤0.01% | 1279 |
|
|
2019
Q4 | $973K | Buy |
3,005
+513
| +21% | +$166K | ﹤0.01% | 1449 |
|
|
2019
Q3 | $681K | Sell |
2,492
-446
| -15% | -$122K | ﹤0.01% | 1592 |
|
|
2019
Q2 | $1.57M | Buy |
2,938
+224
| +8% | +$119K | 0.01% | 1182 |
|
|
2019
Q1 | $1.37M | Buy |
2,714
+265
| +11% | +$134K | 0.01% | 1206 |
|
|
2018
Q4 | $1.21M | Sell |
2,449
-78
| -3% | -$38.5K | 0.01% | 1207 |
|
|
2018
Q3 | $2.31M | Sell |
2,527
-153
| -6% | -$140K | 0.01% | 992 |
|
|
2018
Q2 | $1.96M | Sell |
2,680
-919
| -26% | -$673K | 0.01% | 1038 |
|
|
2018
Q1 | $5.74M | Buy |
3,599
+277
| +8% | +$441K | 0.03% | 605 |
|
|
2017
Q4 | $2.98M | Buy |
3,322
+423
| +15% | +$379K | 0.02% | 842 |
|
|
2017
Q3 | $1.04M | Buy |
2,899
+9
| +0.3% | +$3.24K | 0.01% | 1238 |
|
|
2017
Q2 | $847K | Buy |
2,890
+286
| +11% | +$83.8K | 0.01% | 1327 |
|
|
2017
Q1 | $917K | Buy |
2,604
+117
| +5% | +$41.2K | 0.01% | 1213 |
|
|
2016
Q4 | $457K | Sell |
2,487
-283
| -10% | -$52K | ﹤0.01% | 1562 |
|
|
2016
Q3 | $714K | Buy |
2,770
+970
| +54% | +$250K | 0.01% | 1263 |
|
|
2016
Q2 | $384K | Sell |
1,800
-54
| -3% | -$11.5K | ﹤0.01% | 1533 |
|
|
2016
Q1 | $382K | Sell |
1,854
-106
| -5% | -$21.8K | ﹤0.01% | 1505 |
|
|
2015
Q4 | $495K | Buy |
1,960
+594
| +43% | +$150K | ﹤0.01% | 1342 |
|
|
2015
Q3 | $224K | Buy |
1,366
+433
| +46% | +$71K | ﹤0.01% | 1706 |
|
|
2015
Q2 | $175K | Buy |
+933
| New | +$175K | ﹤0.01% | 1892 |
|